Aprea Therapeutics, Inc. Share Price & Technical Analysis
APRE · $0.95 (+2.15%)
Healthcare / Biotechnology
$0.95
+2.15%
Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways. Its lead product candidates are APR-1051, an orally bioavailable small-molecule inhibitor of WEE1 kinase that is in Phase 1 clinical trial for the treatment of patients with advanced solid tumo…
Price chart
Seasonality
May has 1 positive and 3 negative years (last 5 years shown)
13% return in May, -3% avg return in past 3 year May month.
33% return in 2026, -40% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -11% | 29% | -11% | 14% | 13% | – | – | – | – | – | – | – | 33% |
| 25 | 22% | -36% | -20% | -15% | 0% | 0% | 0% | -11% | -6% | -7% | -7% | -25% | -105% |
| 24 | 11% | 60% | -21% | -23% | -6% | -13% | -10% | -6% | -15% | 44% | -26% | 10% | 7% |
| 23 | 28% | -48% | -15% | -9% | -3% | -18% | -3% | 16% | 11% | -17% | 6% | 31% | -22% |
| 22 | -27% | -18% | 6% | -22% | -42% | -12% | 28% | -14% | -16% | 1% | -38% | -21% | -174% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Downtrend · Uptrend
Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways. Its lead product candidates are APR-1051, an orally bioavailable small-molecule inhibitor of WEE1 kinase that is in Phase 1 clinical trial for the treatment of patients with advanced solid tumors with biomarkers and ATRN-119, an ATR inhibitor, which is in Phase 1/2a clinical trial for solid tumor indications. The company is headquartered in Doylestown, Pennsylvania.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$11.47M
P/E ratio
—
52W high
$2.22
52W low
$0.55
Volume
1,90,007
Beta
1.52
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Aprea Therapeutics, Inc. share price today?
- Aprea Therapeutics, Inc. (APRE) last traded around $0.95 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does APRE have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for APRE. Download the app for real-time alerts.
- How can I analyze Aprea Therapeutics, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.